Suchergebnisse - "1474-0338" OR "1744-764X"

PubPharm (9)

1

Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents

enthalten in: Expert opinion on drug safety | 2023

von McIntyre, R.

2

Can COVID-19 have a clinically significant effect on drug metabolism?

enthalten in: Expert opinion on drug safety | 2023

von Ceban, F. | Subramaniapillai, M. | Rosenblat, J. | +2

3

Vortioxetine in major depressive disorder : from mechanisms of action to clinical studies. An updated review

enthalten in: Expert opinion on drug safety | 2022

von De Diego-Adeliño, J. | Crespo, J. | Mora, F. | +4

4

Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer

enthalten in: Expert opinion on drug safety | 2022

von Lau, D. | Mencel, J. | Chau, I.

5

Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer

enthalten in: Expert opinion on drug safety | 2022

von Lau, D. | Mencel, J. | Chau, I.

6

Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review

enthalten in: Expert opinion on drug safety | 2022

von De Diego-Adeliño, J. | Crespo, J. | Mora, F. | +4

7

The safety of pharmacologic treatment for pediatric obesity

enthalten in: Expert opinion on drug safety | 2018

von Chao, A. | Wadden, T. | Berkowitz, R.

8

The safety of sacubitril-valsartan for the treatment of chronic heart failure

enthalten in: Expert opinion on drug safety | 2017

von Tyler, J. | Teerlink, J.

9

DPP-4 inhibitors : pharmacological differences and their clinical implications

enthalten in: Expert opinion on drug safety | 2014

von Ceriello, A. | Sportiello, L. | Rafaniello, C. | +1

1
[1]